Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Autolus Therapeutics (AUTL) stocks in Canada
Learn how to easily invest in Autolus Therapeutics stocks.
Autolus Therapeutics is a biotechnology business based in the US. Autolus Therapeutics stocks (AUTL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $6.57 – a decrease of 5.48% over the previous week. Autolus Therapeutics employs 376 staff and has a trailing 12-month revenue of around $2.6 million.
How to buy shares in Autolus Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AUTL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Autolus Therapeutics?
- Has coronavirus impacted Autolus Therapeutics shares?
- Autolus Therapeutics shares summary
- Compare share dealing platforms
- Is Autolus Therapeutics stock a buy or sell?
- Autolus Therapeutics performance over time
- Autolus Therapeutics's financials
- How volatile are Autolus Therapeutics shares?
- Does Autolus Therapeutics pay a dividend?
- Other common questions
Autolus Therapeutics stock price (NASDAQ:AUTL)Use our graph to track the performance of AUTL stocks over time.
Autolus Therapeutics shares at a glance
|Latest market close||$4.14|
|52-week range||$4.21 - $9.12|
|50-day moving average||$5.80|
|200-day moving average||$6.11|
|Wall St. target price||$15.06|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.22|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Autolus Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Autolus Therapeutics price performance over time
|1 week (2022-01-13)||-5.48%|
|1 month (2021-12-20)||-22.18%|
|3 months (2021-10-20)||-29.83%|
|6 months (2021-07-20)||-32.79%|
|1 year (2021-01-20)||-53.27%|
|2 years (2020-01-17)||-67.01%|
|3 years (2019-01-18)||31.03|
|5 years (2017-01-16)||N/A|
Autolus Therapeutics financials
|Revenue TTM||$2.6 million|
|Gross profit TTM||$-133,173,000|
|Return on assets TTM||-33.53%|
|Return on equity TTM||-59.51%|
|Market capitalisation||$312.8 million|
TTM: trailing 12 months
Autolus Therapeutics share dividends
We're not expecting Autolus Therapeutics to pay a dividend over the next 12 months.
Autolus Therapeutics share price volatility
Over the last 12 months, Autolus Therapeutics's shares have ranged in value from as little as $4.21 up to $9.1155. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Autolus Therapeutics's is 1.4506. This would suggest that Autolus Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Autolus Therapeutics overview
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; AUTO3NG for the treatment of hematological cancer; AUTO4 and AUTO5 for T cell lymphoma; AUTO6NG for the treatment of programmed T cell therapies; AUTO6 for the treatment of neuroblastoma; and AUTO7 for the treatment of prostate cancer. Autolus Therapeutics plc was founded in 2014 and is headquartered in London, the United Kingdom. .
Autolus Therapeutics in the news
Autolus Therapeutics PLC Sponsored ADR (AUTL) Loses 22.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Autolus Therapeutics (AUTL) Developing Next Generation Programmed T Cell Therapies (Slideshow)
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.